The LigaSure Curved, Small Jaw, Open Sealer/Divider instrument will be sold in the U.S. starting this quarter.
According to Covidien’s website, LigaSure technology can fuse vessels, including pulmonary vasculature, up to and including 7 mm, lymphatics and tissue bundles with an average seal cycle of two to four seconds.
Read the Boulder County Business Report on LigaSure.
Read more on device approval:
–FDA Approves EndoSerter Device for Corneal Transplants
–Weight Loss Centers Expect More Business Following FDA Lap-Band Decision
–Anesthesiology Devices Recalled After Weak Oversight by FDA
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
